James Molloy
Stock Analyst at Alliance Global Partners
(0.52)
# 3,840
Out of 4,784 analysts
33
Total ratings
23.53%
Success rate
-38.88%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IGC IGC Pharma | Reiterates: Buy | $3.5 | $0.29 | +1,090.48% | 2 | Mar 6, 2025 | |
| INTS Intensity Therapeutics | Initiates: Buy | $8.5 | $1.95 | +335.90% | 1 | Jan 13, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $35 | $17.35 | +101.73% | 1 | Dec 9, 2024 | |
| GOVX GeoVax Labs | Initiates: Buy | $15 | $1.11 | +1,251.35% | 1 | Nov 11, 2024 | |
| INMB INmune Bio | Initiates: Buy | $20 | $7.52 | +165.96% | 1 | Oct 21, 2024 | |
| SCLX Scilex Holding Company | Initiates: Buy | $14 | $0.24 | +5,654.21% | 1 | Oct 16, 2024 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $600 → $1,100 | $20.17 | +5,353.64% | 7 | Jul 22, 2024 | |
| PED PEDEVCO | Initiates: Buy | $1.75 | $0.70 | +150.00% | 1 | Jul 17, 2024 | |
| PXS Pyxis Tankers | Initiates: Buy | $10 | $3.39 | +194.99% | 1 | Jul 17, 2024 | |
| CHRO Channel Therapeutics | Initiates: Buy | n/a | $1.59 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $14 | $0.97 | +1,343.30% | 2 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.28 | +2,243.75% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $1.00 | +653.77% | 1 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $4.97 | +302.41% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.11 | +620.72% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $3.02 | +131.79% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.27 | +6,199.21% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.01 | +1,484.16% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $0.41 | +3,328.01% | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.09 | +1,276.15% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $0.24 | +99,155.58% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $1.77 | +8,360.24% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $938 | $1.47 | +63,675.51% | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $2.78 | +799.28% | 1 | Oct 4, 2021 |
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.29
Upside: +1,090.48%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $1.95
Upside: +335.90%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $17.35
Upside: +101.73%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $1.11
Upside: +1,251.35%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $7.52
Upside: +165.96%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $14
Current: $0.24
Upside: +5,654.21%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600 → $1,100
Current: $20.17
Upside: +5,353.64%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.70
Upside: +150.00%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $3.39
Upside: +194.99%
Channel Therapeutics
Jun 18, 2024
Initiates: Buy
Price Target: n/a
Current: $1.59
Upside: -
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $0.97
Upside: +1,343.30%
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.28
Upside: +2,243.75%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $1.00
Upside: +653.77%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $4.97
Upside: +302.41%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.11
Upside: +620.72%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $3.02
Upside: +131.79%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $1.27
Upside: +6,199.21%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $1.01
Upside: +1,484.16%
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $0.41
Upside: +3,328.01%
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $1.09
Upside: +1,276.15%
Sep 7, 2022
Initiates: Buy
Price Target: $240
Current: $0.24
Upside: +99,155.58%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $1.77
Upside: +8,360.24%
Jun 1, 2022
Initiates: Buy
Price Target: $938
Current: $1.47
Upside: +63,675.51%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $2.78
Upside: +799.28%